Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

6082 ARTÍCULOS , VIENDO DEL 691 AL 705

Leader and Follower Roles in Adapted Tango Reveal Complementary Neural Routes to Motor Improvement in Parkinson's Disease

Theofanopoulou C, Bajaj N, Sánchez AM, Crosson B, Wolf SL, Krishnamurthy V, McGregor KM, Hackney ME.

medRxiv [Preprint]. 2026 Sep 15:2026.09.14.26362964. doi: 10.64898/2026.09.14.26362964.

On-demand therapies-emergency medication or daily routine?

Weise D, Gandor F.

J Neural Transm (Vienna). 2026 Sep 24. doi: 10.1007/s00702-026-03288-9. Online ahead of print.

Beyond bacteria: a multi-omics view of the gut-brain axis in Parkinson's disease

Han H, Luo O, Li K, Rahaman S, Ok EU, Zhang L, Liang M, Lin H.

Front Cell Infect Microbiol. 2026 Sep 11;16:1900578. doi: 10.3389/fcimb.2026.1900578. eCollection 2026.

Efficacy and Safety of Photobiomodulation Therapy for Motor Symptoms in Parkinson's Disease: A Systematic Review and Meta-Analysis

Mariano J, Piña Mojica E, Soto-Rodríguez A, Gianlorenço AC, Pacheco-Barrios K, Fregni F.

Brain Sci. 2026 Aug 31;16(9):925. doi: 10.3390/brainsci16090925.

Neuroinflammation and Graft Survival in Pluripotent Stem Cell-Derived Therapies for the Central Nervous System

Sánchez L, Rodriguez CM, Pitossi FJ.

J Neurochem. 2026 Sep;170(9):e70540. doi: 10.1111/jnc.70540.

Role of arbutin and acetoside against Parkinson's disease

Singh A, Dalal D, Singh L.

Indian J Pharmacol. 2026 Sep 1;58(5):495-504. doi: 10.4103/ijp.ijp_68_26. Epub 2026 Sep 2.

Na(V)1.7-dependent peripheral sensitization drives chronic pain in Parkinson's disease

Nelson TS, Grabus NK, Allen HN, Calderon-Rivera A, Loya-Lopez S, Rodriguez-Palma EJ, Waters AL, Elhanafy E, Shiers SI, Sankaranarayanan I, Gomez K, Price TJ, Khanna R.

bioRxiv [Preprint]. 2026 Sep 15:2026.09.09.750469. doi: 10.64898/2026.09.09.750469.

Pharmacological treatment of sleep disorder phenotypes in Parkinson's disease: a systematic review and meta-analysis of randomised controlled trials

Canever JB, da Silva LC, Apio FS, Cimarosti HI.

J Neurol. 2026 Sep 24;273(10):618. doi: 10.1007/s00415-026-14158-5.

A review of FDG-PET biomarker analysis methods in Parkinson's disease

Reimers E, Bevington C, Stoessl AJ, Sossi V.

J Parkinsons Dis. 2026 Sep 26:1877718X261492275. doi: 10.1177/1877718X261492275. Online ahead of print.

Harnessing Voice Analysis and Machine Learning for Early Diagnosis of Parkinson's Disease: A Comparative Study Across Three Datasets

Neto OP.

J Voice. 2026 Sep;40(5):1304-1310. doi: 10.1016/j.jvoice.2024.04.020. Epub 2024 May 12.

Non-motor symptoms in Parkinson's disease: a practical approach

Subota A, Bruno V.

Pract Neurol. 2026 Sep 20;26(5):456-463. doi: 10.1136/pn-2025-004696.

[Tremor]

Baltar-Yanes F, Mahfoud-Hawilou A, Pérez-Vidarte F, Vides M, Paz Debitonto-Varini M, Zea Vera A.

Medicina (B Aires). 2026 Aug;86 Suppl 3:137-148.

α-Synuclein Pathology in Idiopathic Normal Pressure Hydrocephalus: Evidence for Concomitant Synucleinopathy and Clinical Implications

Pyrgelis ES, Paraskevas GP, Constantinides VC, Boufidou F, Stefanis L, Kapaki E.

Diagnostics (Basel). 2026 Sep 8;16(18):2889. doi: 10.3390/diagnostics16182889.

How Language Shapes Mechanistic Thinking in Parkinson Disease

Espay AJ, Lees AJ.

Neurology. 2026 Oct 13;107(7):e218510. doi: 10.1212/WNL.0000000000218510. Epub 2026 Sep 15.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias